Serum Institute of India will manufacture Valneva's anti-Chikungunya vaccine for India and select Asian markets, addressing a major public health issue.
Vespa.ai, the creator of a leading platform for building and deploying large-scale, real-time AI applications powered by big data, today announced its recognition as a Leader and Forward Mover in the ...